Clinical biospecimen samples in the DCN Dx laboratory

Prospective
Biospecimen Collections

Built for IVD Evidence

Prospective Collections
for IVD Evidence

We design and operationalize IRB/IEC-approved prospective collections mapped to your claims and evidence plan.

Study Types Supported

.01

Research and proof of concept

.02

Analytical validation

.03

Clinical performance

.04

Positivity enrichment

.05

Rare matrices

.06

CLIA-Waiver flex

.07

Reproducibility

.08

Bridging and lot release

Designed for
IVD Programs

Our prospective collections service provides a traceable chain of custody and is engineered for IVD programs.

Matched specimens, matrices, or panels aligned to protocol and intended use.

Positivity enrichment or targeted recruitment for low prevalence conditions.

Flex studies of truly naïve operators, captured under controlled methods.

Representative
Programs

.01

Research

Assay proof of concept studies, clinical validity of biomarker studies.

.02

Analytical Validation

Sensitivity, LoD, specificity, precision, reference interval, stability.

.03

CLIA-Waiver Flex Studies

Intended use environments, naïve operators, operator variability capture.

.04

Clinical Performance

Real-world positivity‑enriched cohorts, targeted recruitment, reference standard/comparator benchmarks, and study design.

.05

All Matrices and Special Handling

Saliva, capillary blood, nasal swabs, stool, urine, plasma/serum, others.

How It Works

We provide end-to-end operational ownership with clear handoffs, SLAs, and audit-ready documentation:

Expertise

01

CORE team – Industry builders/leaders.

Speed

02

Qualified network + proven workflows; Rapid accrual – delivery.

Compliance

03

Quality, Clinical & Regulatory compliance from day one.

Service

04

Dedicated team for personalized client support.

Quality & Compliance

We operate under a CRO grade quality system aligned to ICH GCP, with privacy and data protection controls appropriate to each program.

.01

ICH-GCP

.02

Audit Trails & Access Control

.03

Chain of Custody

.04

PHI & Privacy (HIPAA/GDPR)

.05

Document Control & Training Records

.06

Temperature Monitoring & Alarms

Cohorts & Metrics

Targeted recruitment and pre‑screening strategies for low‑prevalence cohorts, aligned to protocol needs.

Healthy, symptomatic, and adjudicated cohorts available; multi‑region site networks as required.

Full material traceability and storage conditions documented; customizable panel assembly.

Targeted recruitment for indications including cancer, neurological, cardiac, diabetes, and infectious disease.

Key attributes that are targeted include Ethnic Diversity, Treatment Naïve, and Longitudinal Collections.

About-Team-Hero-(2)
Experts on your side

Need support driving your IVD forward? Reach out to DCN Dx Experts for solutions.

About-Team-Hero-(2)

Recent Insights

related links

Next Steps

Let’s Get This Project Started

Subscribe to the DCN Dx Newsletter

Get in touch

3193 Lionshead Ave
Suite 200
Carlsbad, CA 92010
USA

No products in the cart.

[biospecimens_menu_source]